Journal of Veterinary Clinics (한국임상수의학회지)

The Korean Society of Veterinary Clinics (한국임상수의학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Clinical Efficacy and Safety Following Kyungokgo-Gamibang Administration in Dogs with Skin and Joint Diseases

  • Ga-Won Lee (Department of Companion Animal Industry, College of Health and Welfare, Dongshin University) ;
  • Heyong-Seok Kim (Petobio, Inc.) ;
  • Jong-Won Kim (Petobio, Inc.) ;
  • Yang-Seon Moon (Nawoori (Ltd)) ;
  • Chang-Su Na (Department of Korean Diagnostics, College of Korean Medicine, Dongshin University)
  • Received : 2022.10.11
  • Accepted : 2023.03.20
  • Published : 2023.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Skin and joint diseases are relatively common in dogs. Nutritional complementation is one of the various management strategies for these disorders. This study evaluated the safety and clinical efficacy of Kyungokgo-gamibang in dogs with skin and joint diseases. Thirty dogs with diseases were included and divided into three groups: control group (n = 15), skin group (n = 10), and joint group (n = 5). The skin and joint groups were fed skin and joint gums composed of Kyungokgo-gamibang extract with standard treatment for four weeks. The control group included dogs with skin diseases who were administered standard skin infection treatment for 4 weeks. The physical and laboratory results showed no remarkable adverse effects of Kyungokgo-gamibang extract after its administration in dogs. Clinical efficacy was evaluated using quality of life scale, and levels of cytokines, including interferon-γ, interleukin (IL)-2, IL-6, IL-8, IL-10, monocyte chemoattractant protein-1, and tumor necrosis factor-α, for 4 weeks in all groups. Dermatologic clinical scales were performed for 4 weeks in the control and skin groups. Both the control and skin groups had significantly decreased dermatologic clinical scales, including pruritus and erythema scales (p < 0.05). Among the cytokine levels, only IL-2 concentration was significantly decreased in the skin group after 4 weeks of administration of the Kyungokgo-gamibang extract (p = 0.032). There was no significant difference between the levels of cytokines on days 0 and 28 in the joint group. The quality of life scale was significantly increased after week 4 compared to week 0 in the skin (p = 0.008) and joint groups (p = 0.041). This study suggests that Kyungokgo-gamibang extract can be applied in managing dogs affected by skin and joint diseases without adverse effects.

Keywords

Acknowledgement

This work was partly supported by the Jeollanam-do '2021 R&D supporting program' of Jeonnam Technopark and the Technology development Program of MSS (S3251447).

References

  1. Arsevska E, Singleton DA, Jewell C, Paterson S, Jones PH, Smyth S, et al. Small animal disease surveillance: pruritus and Pseudomonas skin infections. Vet Rec 2018; 183: 182-187.  https://doi.org/10.1136/vr.k3462
  2. Byard RW, Musgrave I. The potential side effects of herbal preparations in domestic animals. Forensic Sci Med Pathol 2021; 17: 723-725.  https://doi.org/10.1007/s12024-021-00418-5
  3. Gaffen SL, Liu KD. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004; 28: 109-123.  https://doi.org/10.1016/j.cyto.2004.06.010
  4. Guillot J, Bond R. Malassezia yeasts in veterinary dermatology: an updated overview. Front Cell Infect Microbiol 2020; 10: 79. 
  5. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008; 226: 19-28.  https://doi.org/10.1111/j.1600-065X.2008.00697.x
  6. Hwang YH, Kim KJ, Kim JJ, Kang KY, Lee SJ, Jeong GY, et al. Antiosteoporosis activity of new oriental medicine preparation (Kyungokgo mixed with water extract of Hovenia dulcis) on the ovariectomized mice. Evid Based Complement Alternat Med 2015; 2015: 373145. 
  7. Lee ES, Seo BI, Lee JW, Bae JS. The immunological activities of Kyungohkgo and prescription of modified Kyungohkgo. Korea J Herbol 2002; 17: 10-100. 
  8. Lee KS, Kim GH, Kim HH, Seong BJ, Kim SI, Han SH, et al. Qualities and anti-inflammatory activity of Kyungokgos sold in local markets. J Korean Soc Food Sci Nutr 2013; 42: 335-341.  https://doi.org/10.3746/jkfn.2013.42.3.335
  9. Lin YC, Huang YC, Wang YS, Juang RH, Liao KW, Chu RM. Canine CD8 T cells showing NK cytotoxic activity express mRNAs for NK cell-associated surface molecules. Vet Immunol Immunopathol 2010; 133: 144-153.  https://doi.org/10.1016/j.vetimm.2009.07.013
  10. Marchegiani A, Fruganti A, Spaterna A, Dalle Vedove E, Bachetti B, Massimini M, et al. Impact of nutritional supplementation on canine dermatological disorders. Vet Sci 2020; 7: 38. 
  11. Musco N, Vassalotti G, Mastellone V, Cortese L, Della Rocca G, Molinari ML, et al. Effects of a nutritional supplement in dogs affected by osteoarthritis. Vet Med Sci 2019; 5: 325-335.  https://doi.org/10.1002/vms3.182
  12. Na CS, Shin W, Lee YM, Moon YS, Noh HK, Seo SH, et al. Effect of original Kyungokgo & Iksuyongjingo plus Sparassis crispa on antioxidant, immunity improvement and sensory evaluation. Korea J Herbol 2016; 31: 43-51.  https://doi.org/10.6116/kjh.2016.31.4.43.
  13. Nuttall T, Bensignor E. A pilot study to develop an objective clinical score for canine otitis externa. Vet Dermatol 2014; 25: 530-537, e91-e92. 
  14. Paterson S. Food hypersensitivity in 20 dogs with skin and gastrointestinal signs. J Small Anim Pract 1995; 36: 529-534.  https://doi.org/10.1111/j.1748-5827.1995.tb02803.x
  15. Pedersen NC, Pool R. Canine joint disease. Vet Clin North Am 1978; 8: 465-493.  https://doi.org/10.1016/S0091-0279(78)50055-5
  16. Richardson DC, Schoenherr WD, Zicker SC. Nutritional management of osteoarthritis. Vet Clin North Am Small Anim Pract 1997; 27: 883-911.  https://doi.org/10.1016/S0195-5616(97)50085-4
  17. Song DW, Lee GW, Ro WB, Kim HS, Kang HM, Kim JW, et al. Safety evaluation of Kyungokgo-gamibang administration based on hematological, biochemical, protein, and lipid profiles in dogs. J Vet Clin 2021; 38: 7-15.  https://doi.org/10.17555/jvc.2021.02.38.1.7
  18. Spitznagel MB, Patrick K, Hillier A, Gober M, Carlson MD. Caregiver burden, treatment complexity, and the veterinarian-client relationship in owners of dog with skin disease. Vet Dermatol 2022; 33: 208-213.  https://doi.org/10.1111/vde.13065
  19. Sunwoo YY, Kim HJ, Kim JY, Yang NR, Lee JH, Park TY. Hematologic and serological investigation of effect on Gyeongokgo in healthy individuals: a randomized, subject-assessor-blind, placebo-controlled, single-center pilot study. J Physiol Pathol Korean Med 2019; 33: 239-248.  https://doi.org/10.15188/kjopp.2019.08.33.4.239
  20. Villalobos AE. Quality-of-life assessment techniques for veterinarians. Vet Clin North Am Small Anim Pract 2011; 41: 519-529.  https://doi.org/10.1016/j.cvsm.2011.03.013
  21. Whang WK, Oh IS, Lee SH, Choi SB, Kim IH. The physiological activities of Kyung Ok-Ko(II) -effects on the hyperglycemia, hypertension, anti-fatigue and decrease of body weight-. Korean J Pharmacogn 1994; 25: 51-58.